Israel stocks higher at close of trade; TA 35 up 0.47%

Investing.com – Israel stocks were higher after the close on Tuesday, as gains in the , and sectors led shares higher.

At the close in Tel Aviv, the gained 0.47% to hit a new 6-months high.

The best performers of the session on the were Teva Pharmaceutical Industries Ltd (TASE:), which rose 11.21% or 282 points to trade at 2797 at the close. Meanwhile, Ormat Technologies (TASE:) added 3.53% or 930 points to end at 27290 and Paz Oil (TASE:) was up 2.87% or 1480 points to 52980 in late trade.

The worst performers of the session were Liveperson (TASE:), which fell 4.65% or 650 points to trade at 13340 at the close. Delek Drilling LP (TASE:) declined 2.79% or 25 points to end at 877 and Airport City Ltd (TASE:) was down 2.55% or 175 points to 6694.

Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 231 to 164 and 21 ended unchanged.

Shares in Ormat Technologies (TASE:) rose to all time highs; up 3.53% or 930 to 27290.

Crude oil for December delivery was up 1.48% or 0.79 to $54.30 a barrel. Elsewhere in commodities trading, Brent oil for delivery in December rose 0.95% or 0.56 to hit $59.52 a barrel, while the December Gold Futures contract fell 0.16% or 2.45 to trade at $1485.65 a troy ounce.

USD/ILS was down 0.23% to 3.5319, while EUR/ILS fell 0.31% to 3.9343.

The US Dollar Index Futures was up 0.08% at 97.123.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.